Received by email:

File: XCX_NR_New Directors and Officers_02jan19.docx



/
Chinook Announces New Directors and Officers

ERFURT, GERMANY, January 2nd, 2019 | Chinook Tyee Industry Limited (the "Company") (TSXV: XCX) announces that Dr. Stef
--->an Feuerstein and Messrs. Alex Blodgett, Claudio Morandi and Ken MacLeod were elected to the board of directors at the
---> Company's shareholder meeting.

Dr. Stefan Feuerstein who is also Managing Director of AMP Alternative Medical Products GmbH, a wholly owned subsidiar
--->y of the Company, was appointed President while Mr. Blodgett was appointed Chief Executive Officer of the Company.

About AMP Alternative Medical Products
AMP Alternative Medical Products GmbH, is a German biopharmaceutical company that provides cannabis as a medicine to G
--->erman patients by importing EU-GMP medical cannabis into Germany from Canada.  Canadian licence producers (LP) that en
--->ter into supply contracts with AMP are audited to ensure they meet the stringent EU-GMP standards before AMP arranges 
--->EU-GMP certification in Germany to allow importation.  AMP is based in Erfurt in the state of Thuringia in central Ger
--->many and with offices in Berlin and Vancouver, Canada.  For further information, visit www.amp-eu.com, Twitter or Inst
--->agram.

About Chinook 
Chinook Tyee Industry Limited is a European investment holding company that trades on the TSX Venture Exchange under t
--->he symbol, "XCX".  Chinook has 10,217,796 fully diluted shares issued and outstanding, and its primary investment is A
--->MP Alternative Medical Products GmbH.
Neither the TSXV nor its Regulation Service Provider (as that term is defined in the policies of the TSXV) accepts res
--->ponsibility for the adequacy or accuracy of this release.

For further information, please contact:
 Mr. Alex Blodgett 
Tel: +1 (236) 833-1602
Email: investor@amp-eu.com
SOURCE Chinook Tyee Industry Limited